Sentence examples for divided npc from inspiring English sources
Li et al. divided NPC into four RT-related types: radiosensitive and non metastasis-prone, radioresistanon metastasis-prones-pradioresistantsitive and metastasis-pronon metastasis-pronenon metastasis-proneone [ 33].
We then characterise NvAth-like (Atonal/Neurogenin family) as a positive regulator of neurogenesis that is co-expressed with NvSoxB(2) in a subset of dividing NPCs, while we find that NvAshA (Achaete-scute family) and NvSoxB(2) are co-expressed in non-dividing cells only.
Immunohistochemical staining was performed in 274 paraffin-embedded NPC specimens divided into a training set (n = 120) and a testing set (n = 154).
Xiao et al. [3] divided 362 early-stage NPC patients treated with 2D-CRT alone into four subgroups (T1N0M0, T2N0M0, T1N1M0, and T2N1M0) and found that the treatment outcome of the T2N1M0 subgroup was a unique group with the poorest prognosis because of distant metastasis.
Recent structural and transport studies of the NPC indicated that the interior of the NPC is concentrically divided into central and peripheral routes by hydrophobic FG-rich nups to spatially regulate molecular transport at the nanometer scale.
Acc ording to WHO classification, NPC is histopathologically divided into three categories: keratinizing squamous cell carcinoma (WHO type I), non-keratinizing squamous cell carcinoma (WHO type II), and undifferentiated carcinoma (WHO type III).
The 274 NPC FFPE specimens were randomly divided into a training set and a testing set using a random number table generated by SPSS 16.0 software (SPSS, Chicago, IL, USA).
Thirteen weeks after the injury they were divided into four groups and received either: 1. Medium (control), 2. NPC transplants, 3. NPC + lentivirus vector expressing chondroitinase, or 4. NPC + lentivirus vectors expressing chondroitinase and neurotrophic factors.
Our previous study showed that ESC neural differentiation could be divided into two stages: ESCs to EpiSCs and EpiSCs to NPCs (Zhang et al., 2010a).
To determine the clinical significance of BRMS1 in NPC patients, we detected BRMS1 expression by immunohistochemistry in 274 tumor specimens which were randomly divided into a training set (n = 120) and a testing set (n = 154).
